
Season's Greetings
TWINCORE wishes you happy holidays and a successful new year

TWINCORE was founded in 2008 by the Helmholtz Centre for Infection Research and the Hannover Medical School. We combine the expertise of medical professionals and scientists from a wide range of disciplines to find answers to the pressing questions in infection research. Our focus: translational research – the bridge between basic science and clinical application.

TWINCORE wishes you happy holidays and a successful new year

zukunft.niedersachsen provides €2.7 million in funding for joint project on rare diseases

€100,000 from the German Society for Parkinson's Disease and Movement Disorders
We conduct translational infection research to improve the prevention, diagnosis and treatment of infectious diseases in humans. We focus on three areas that characterize our research work. Find out here how we proceed and what results we achieve.
Under the leadership of our best scientists, various labs are working on different projects within our research topics.
Kumar S, Li C, Zhou L, Zhan Q, Alaswad A, Volland S, Costa B, Krooss S, Klefenz I, Schmaus H, Zeuzem A, von Witzendorff D, Lickei H, Pueschel L, Kraft A, Cornberg M, Koczulla A, Pink I, Hoeper M, Xu C, Häussler S, Wiestler M, Netea M, Illig T, Sun J, Li Y
Bosc L, Sécher T, Ball G, Le Pennec D, Tribout M, Ba M, Bai Y, Ouerdane L, Arnoux P, Denis Y, Lei X, Bordi C, Heuzé-Vourc'h N, Häussler S, Gomez N, Voulhoux R
Paasch D, Schevel H, Riehle A, Costa B, Toufaili H, Gehnen T, Dahlmann J, Pavlou A, Neehus A, Nguyen A, Schiering E, Buchegger T, Bustamante J, Hansen G, Kalinke U, Gulbins E, Grassmé H, Lachmann N
The project investigates how HCMV is recognized by the immune system and which mechanisms the virus uses to camouflage itself. The aim is to understand the immune reactions and develop therapies for severely affected patients.
We are investigating how antibodies protect against HCV infection, in particular what properties they have during a healing infection. The aim is to identify antibodies that are important for an effective vaccine against HCV.
We are investigating why HCV infections sometimes heal spontaneously, but often become chronic, and why RSV infections are severe in some children. We use modern sequencing technologies to analyze the genetic characteristics of hosts and pathogens in order to understand susceptibility.
Human, potentially neutralizing antibodies against HEV have advanced the development of new detection methods for the virus in patient samples. Serological and functional analyses are used to determine markers for the course and treatment of chronic infections.
There are currently no events.

